 |
|
Impact of Recommendations to Suspend the Birth Dose of Hepatitis B Virus Vaccine
Ronda J. Oram, MD;
Robert S. Daum, MD;
John B. Seal, MA;
Diane S. Lauderdale, PhD
JAMA. 2001;285:1874-1879.
Context In July 1999, due to concerns about thimerosal content, the American Academy of Pediatrics (AAP) and the Public Health Service (PHS) recommended suspending hepatitis B virus (HBV) vaccination at birth except for mothers who had positive or unknown hepatitis B surface antigen (HBsAg) status. In September 1999, the Centers for Disease Control and Prevention recommended that hospitals resume HBV vaccination at birth with a new thimerosal-free vaccine. Whether the 2 changes in recommendations within 3 months led to less-than-optimal compliance in hospital nurseries is unknown.
Objective To determine hospital HBV vaccination policy before the recommendation for delay of HBV vaccination and 1 year later.
Design, Setting, and Participants Survey of all 46 hospitals with obstetric services and neonatal nurseries in Cook County, Illinois.
Main Outcome Measures Hepatitis B virus immunization practices before July 1999 and in August 2000; hospital factors associated with routine HBV immunization and compliance with AAP and PHS recommendations.
Results Before July 1999, 74% of surveyed hospital nurseries offered HBV vaccine to all neonates; only 39% did so in August 2000. Being located in the Chicago city limits (88% vs 57%; P = .02) and having an academic affiliation (93% vs 66%; P = .05) were positively associated with routine neonatal immunization before July 1999. Both academic affiliation and city location were associated with routine immunization in August 2000 (71% vs 25% [P = .003] and 60% vs 14% [P = .002], respectively) and with compliance with recommendations for suspension (57% vs 25% [P = .03] and 56% vs 10% [P = .001]).
Conclusions We documented a 35% decrease in hospital nurseries that routinely offered HBV immunization 1 year after the AAP and PHS recommendations were made. Special efforts may be required to make at-birth administration of HBV vaccination universal.
Author Affiliations: Pediatric Immunization Program and Departments of Pediatrics (Drs Oram and Daum and Mr Seal) and Health Studies (Dr Lauderdale), the University of Chicago, Chicago, Ill.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTER
Hepatitis B Vaccination for Newborns
Erdem I. Cantekin, Michael Belkin, Ronda J. Oram, Diane S. Lauderdale, John B. Seal, and Robert S. Daum
JAMA. 2001;286(5):535-536.
EXTRACT
| FULL TEXT
RELATED ARTICLE
April 11, 2001
JAMA. 2001;285(14):1903-1904.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Impact of the 2004 Influenza Vaccine Shortage on Repeat Immunization Rates
Schade and Hannah
Ann Fam Med 2006;4:541-547.
ABSTRACT
| FULL TEXT
The Immunologic Basis for Neonatal Immunizations
Baley and Leonard
NeoReviews 2005;6:e463-e470.
FULL TEXT
Assessment of Perinatal Hepatitis B and Rubella Prevention in New Hampshire Delivery Hospitals
Bascom et al.
Pediatrics 2005;115:e594-e599.
ABSTRACT
| FULL TEXT
Pediatricians' Self-reported Clinical Practices and Adherence to National Immunization Guidelines After the Introduction of Pneumococcal Conjugate Vaccine
Lee et al.
Arch Pediatr Adolesc Med 2004;158:695-701.
ABSTRACT
| FULL TEXT
Impact of Thimerosal-Related Changes in Hepatitis B Vaccine Birth-Dose Recommendations on Childhood Vaccination Coverage
Luman et al.
JAMA 2004;291:2351-2358.
ABSTRACT
| FULL TEXT
Impact of the Thimerosal Controversy on Hepatitis B Vaccine Coverage of Infants Born to Women of Unknown Hepatitis B Surface Antigen Status in Michigan
Biroscak et al.
Pediatrics 2003;111:e645-649.
ABSTRACT
| FULL TEXT
Reasons Hospitals Give for Not Offering Hepatitis B Vaccine to Low-Risk Newborns
Aiken et al.
CLIN PEDIATR 2002;41:681-686.
ABSTRACT
Hepatitis B Vaccination for Newborns
Cantekin et al.
JAMA 2001;286:535-536.
FULL TEXT
AAP News 2001;18:246-246.
FULL TEXT
|
